Oncostatin M and its role in fibrosis

Oncostain M, a member of the IL-6 family of cytokines, is produced by immune cells in response to infections and tissue injury. OSM has a broad, often context-dependent effect on various cellular processes including differentiation, hematopoiesis, cell proliferation, and cell survival. OSM signaling...

Full description

Saved in:
Bibliographic Details
Published in:Connective tissue research 2019-01, Vol.60 (1), p.40-49
Main Authors: Stawski, Lukasz, Trojanowska, Maria
Format: Article
Language:English
Subjects:
Animals
ECM
Fibrosis
Humans
inflammation
Inflammation - pathology
Models, Biological
Oncostatin M - metabolism
OSM
Signal Transduction
vascular injury
Vascular System Injuries - metabolism
Vascular System Injuries - pathology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c468t-ba151632a5714df29eec7129fb17a479c668d6930569a469509e6e0993d9684d3
cites cdi_FETCH-LOGICAL-c468t-ba151632a5714df29eec7129fb17a479c668d6930569a469509e6e0993d9684d3
container_end_page 49
container_issue 1
container_start_page 40
container_title Connective tissue research
container_volume 60
creator Stawski, Lukasz
Trojanowska, Maria
description Oncostain M, a member of the IL-6 family of cytokines, is produced by immune cells in response to infections and tissue injury. OSM has a broad, often context-dependent effect on various cellular processes including differentiation, hematopoiesis, cell proliferation, and cell survival. OSM signaling is initiated by binding to type I (LIFRβ/gp130) or type II (OSMRβ/gp130) receptor complexes and involves activation of Janus kinase/signal transducer and activator of transcription, mitogen-activated protein kinase, and phosphatidylinositol-3-kinase. High levels of OSM have been detected in many chronic inflammatory conditions characterized by fibrosis, giving a rationale to target OSM for the treatment of these diseases. Here we discuss the current knowledge on the role of OSM in various stages of the fibrotic process including inflammation, vascular dysfunction, and activation of fibroblasts.
doi_str_mv 10.1080/03008207.2018.1500558
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6349219</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2079946818</sourcerecordid><originalsourceid>FETCH-LOGICAL-c468t-ba151632a5714df29eec7129fb17a479c668d6930569a469509e6e0993d9684d3</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMo7vrxE5ReBC9dJ02TJhdRFr9gZS96DmmbaqRN1qSr7L83ZT_Qi6fA5Jl3Zh6EzjBMMHC4AgLAMygmGWA-wRSAUr6HxphBkfKc8H00Hph0gEboKIQPAExIRg_RKNYpK5gYo4u5rVzoVW9s8pwoWyemD4l3rU5ipTGld8GEE3TQqDbo0817jF7v716mj-ls_vA0vZ2lVc54n5YKU8xIpmiB87rJhNZVgTPRlLhQeSEqxnjNBInDhcqZoCA00yAEqQXjeU2O0fU6d7EsO11X2vZetXLhTaf8Sjpl5N8fa97lm_uSjOQiwyIGXG4CvPtc6tDLzoRKt62y2i2DjC6EiLtiHlG6Rqt4YvC62Y3BIAfFcqtYDorlRnHsO_-9465r6zQCN2vA2Mb5Tn0739ayV6vW-cYrW5kgyf8zfgAFMYkG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2079946818</pqid></control><display><type>article</type><title>Oncostatin M and its role in fibrosis</title><source>Taylor and Francis Science and Technology Collection</source><creator>Stawski, Lukasz ; Trojanowska, Maria</creator><creatorcontrib>Stawski, Lukasz ; Trojanowska, Maria</creatorcontrib><description>Oncostain M, a member of the IL-6 family of cytokines, is produced by immune cells in response to infections and tissue injury. OSM has a broad, often context-dependent effect on various cellular processes including differentiation, hematopoiesis, cell proliferation, and cell survival. OSM signaling is initiated by binding to type I (LIFRβ/gp130) or type II (OSMRβ/gp130) receptor complexes and involves activation of Janus kinase/signal transducer and activator of transcription, mitogen-activated protein kinase, and phosphatidylinositol-3-kinase. High levels of OSM have been detected in many chronic inflammatory conditions characterized by fibrosis, giving a rationale to target OSM for the treatment of these diseases. Here we discuss the current knowledge on the role of OSM in various stages of the fibrotic process including inflammation, vascular dysfunction, and activation of fibroblasts.</description><identifier>ISSN: 0300-8207</identifier><identifier>EISSN: 1607-8438</identifier><identifier>DOI: 10.1080/03008207.2018.1500558</identifier><identifier>PMID: 30056769</identifier><language>eng</language><publisher>England: Taylor &amp; Francis</publisher><subject>Animals ; ECM ; Fibrosis ; Humans ; inflammation ; Inflammation - pathology ; Models, Biological ; Oncostatin M - metabolism ; OSM ; Signal Transduction ; vascular injury ; Vascular System Injuries - metabolism ; Vascular System Injuries - pathology</subject><ispartof>Connective tissue research, 2019-01, Vol.60 (1), p.40-49</ispartof><rights>2018 Informa UK Limited, trading as Taylor &amp; Francis Group 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c468t-ba151632a5714df29eec7129fb17a479c668d6930569a469509e6e0993d9684d3</citedby><cites>FETCH-LOGICAL-c468t-ba151632a5714df29eec7129fb17a479c668d6930569a469509e6e0993d9684d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30056769$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stawski, Lukasz</creatorcontrib><creatorcontrib>Trojanowska, Maria</creatorcontrib><title>Oncostatin M and its role in fibrosis</title><title>Connective tissue research</title><addtitle>Connect Tissue Res</addtitle><description>Oncostain M, a member of the IL-6 family of cytokines, is produced by immune cells in response to infections and tissue injury. OSM has a broad, often context-dependent effect on various cellular processes including differentiation, hematopoiesis, cell proliferation, and cell survival. OSM signaling is initiated by binding to type I (LIFRβ/gp130) or type II (OSMRβ/gp130) receptor complexes and involves activation of Janus kinase/signal transducer and activator of transcription, mitogen-activated protein kinase, and phosphatidylinositol-3-kinase. High levels of OSM have been detected in many chronic inflammatory conditions characterized by fibrosis, giving a rationale to target OSM for the treatment of these diseases. Here we discuss the current knowledge on the role of OSM in various stages of the fibrotic process including inflammation, vascular dysfunction, and activation of fibroblasts.</description><subject>Animals</subject><subject>ECM</subject><subject>Fibrosis</subject><subject>Humans</subject><subject>inflammation</subject><subject>Inflammation - pathology</subject><subject>Models, Biological</subject><subject>Oncostatin M - metabolism</subject><subject>OSM</subject><subject>Signal Transduction</subject><subject>vascular injury</subject><subject>Vascular System Injuries - metabolism</subject><subject>Vascular System Injuries - pathology</subject><issn>0300-8207</issn><issn>1607-8438</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LxDAQhoMo7vrxE5ReBC9dJ02TJhdRFr9gZS96DmmbaqRN1qSr7L83ZT_Qi6fA5Jl3Zh6EzjBMMHC4AgLAMygmGWA-wRSAUr6HxphBkfKc8H00Hph0gEboKIQPAExIRg_RKNYpK5gYo4u5rVzoVW9s8pwoWyemD4l3rU5ipTGld8GEE3TQqDbo0817jF7v716mj-ls_vA0vZ2lVc54n5YKU8xIpmiB87rJhNZVgTPRlLhQeSEqxnjNBInDhcqZoCA00yAEqQXjeU2O0fU6d7EsO11X2vZetXLhTaf8Sjpl5N8fa97lm_uSjOQiwyIGXG4CvPtc6tDLzoRKt62y2i2DjC6EiLtiHlG6Rqt4YvC62Y3BIAfFcqtYDorlRnHsO_-9465r6zQCN2vA2Mb5Tn0739ayV6vW-cYrW5kgyf8zfgAFMYkG</recordid><startdate>20190102</startdate><enddate>20190102</enddate><creator>Stawski, Lukasz</creator><creator>Trojanowska, Maria</creator><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190102</creationdate><title>Oncostatin M and its role in fibrosis</title><author>Stawski, Lukasz ; Trojanowska, Maria</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c468t-ba151632a5714df29eec7129fb17a479c668d6930569a469509e6e0993d9684d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>ECM</topic><topic>Fibrosis</topic><topic>Humans</topic><topic>inflammation</topic><topic>Inflammation - pathology</topic><topic>Models, Biological</topic><topic>Oncostatin M - metabolism</topic><topic>OSM</topic><topic>Signal Transduction</topic><topic>vascular injury</topic><topic>Vascular System Injuries - metabolism</topic><topic>Vascular System Injuries - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stawski, Lukasz</creatorcontrib><creatorcontrib>Trojanowska, Maria</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Connective tissue research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stawski, Lukasz</au><au>Trojanowska, Maria</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oncostatin M and its role in fibrosis</atitle><jtitle>Connective tissue research</jtitle><addtitle>Connect Tissue Res</addtitle><date>2019-01-02</date><risdate>2019</risdate><volume>60</volume><issue>1</issue><spage>40</spage><epage>49</epage><pages>40-49</pages><issn>0300-8207</issn><eissn>1607-8438</eissn><abstract>Oncostain M, a member of the IL-6 family of cytokines, is produced by immune cells in response to infections and tissue injury. OSM has a broad, often context-dependent effect on various cellular processes including differentiation, hematopoiesis, cell proliferation, and cell survival. OSM signaling is initiated by binding to type I (LIFRβ/gp130) or type II (OSMRβ/gp130) receptor complexes and involves activation of Janus kinase/signal transducer and activator of transcription, mitogen-activated protein kinase, and phosphatidylinositol-3-kinase. High levels of OSM have been detected in many chronic inflammatory conditions characterized by fibrosis, giving a rationale to target OSM for the treatment of these diseases. Here we discuss the current knowledge on the role of OSM in various stages of the fibrotic process including inflammation, vascular dysfunction, and activation of fibroblasts.</abstract><cop>England</cop><pub>Taylor &amp; Francis</pub><pmid>30056769</pmid><doi>10.1080/03008207.2018.1500558</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0300-8207
ispartof Connective tissue research, 2019-01, Vol.60 (1), p.40-49
issn 0300-8207
1607-8438
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6349219
source Taylor and Francis Science and Technology Collection
subjects Animals
ECM
Fibrosis
Humans
inflammation
Inflammation - pathology
Models, Biological
Oncostatin M - metabolism
OSM
Signal Transduction
vascular injury
Vascular System Injuries - metabolism
Vascular System Injuries - pathology
title Oncostatin M and its role in fibrosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T05%3A28%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oncostatin%20M%20and%20its%20role%20in%20fibrosis&rft.jtitle=Connective%20tissue%20research&rft.au=Stawski,%20Lukasz&rft.date=2019-01-02&rft.volume=60&rft.issue=1&rft.spage=40&rft.epage=49&rft.pages=40-49&rft.issn=0300-8207&rft.eissn=1607-8438&rft_id=info:doi/10.1080/03008207.2018.1500558&rft_dat=%3Cproquest_pubme%3E2079946818%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c468t-ba151632a5714df29eec7129fb17a479c668d6930569a469509e6e0993d9684d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2079946818&rft_id=info:pmid/30056769&rfr_iscdi=true